1. Home
  2. RAPP vs HFRO Comparison

RAPP vs HFRO Comparison

Compare RAPP & HFRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RAPP
  • HFRO
  • Stock Information
  • Founded
  • RAPP 2022
  • HFRO 2000
  • Country
  • RAPP United States
  • HFRO United States
  • Employees
  • RAPP N/A
  • HFRO N/A
  • Industry
  • RAPP
  • HFRO Finance/Investors Services
  • Sector
  • RAPP
  • HFRO Finance
  • Exchange
  • RAPP Nasdaq
  • HFRO Nasdaq
  • Market Cap
  • RAPP 439.4M
  • HFRO 362.0M
  • IPO Year
  • RAPP 2024
  • HFRO N/A
  • Fundamental
  • Price
  • RAPP $26.59
  • HFRO $6.41
  • Analyst Decision
  • RAPP Strong Buy
  • HFRO
  • Analyst Count
  • RAPP 4
  • HFRO 0
  • Target Price
  • RAPP $37.00
  • HFRO N/A
  • AVG Volume (30 Days)
  • RAPP 1.1M
  • HFRO 179.8K
  • Earning Date
  • RAPP 11-06-2025
  • HFRO 01-01-0001
  • Dividend Yield
  • RAPP N/A
  • HFRO 8.87%
  • EPS Growth
  • RAPP N/A
  • HFRO N/A
  • EPS
  • RAPP N/A
  • HFRO N/A
  • Revenue
  • RAPP N/A
  • HFRO N/A
  • Revenue This Year
  • RAPP N/A
  • HFRO N/A
  • Revenue Next Year
  • RAPP N/A
  • HFRO N/A
  • P/E Ratio
  • RAPP N/A
  • HFRO N/A
  • Revenue Growth
  • RAPP N/A
  • HFRO N/A
  • 52 Week Low
  • RAPP $6.43
  • HFRO $4.24
  • 52 Week High
  • RAPP $42.27
  • HFRO $6.45
  • Technical
  • Relative Strength Index (RSI)
  • RAPP 55.67
  • HFRO 53.48
  • Support Level
  • RAPP $26.05
  • HFRO $6.18
  • Resistance Level
  • RAPP $30.67
  • HFRO $6.83
  • Average True Range (ATR)
  • RAPP 2.04
  • HFRO 0.18
  • MACD
  • RAPP -0.34
  • HFRO -0.05
  • Stochastic Oscillator
  • RAPP 32.21
  • HFRO 33.85

About RAPP Rapport Therapeutics Inc. Common Stock

Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational science has elucidated the complexities of neuronal receptor biology and enables the company to map and target certain neuronal receptor complexes. Neuronal receptors are complex assemblies of proteins, comprising receptor principal subunits and their receptor-associated proteins (RAPs), the latter of which play crucial roles in regulating receptor expression and function.

About HFRO Highland Opportunities and Income Fund of Beneficial Interest

Highland Opportunities and Income Fund is a non-diversified, closed-end management investment company. Its investment objective is to Income Fund seeks growth of capital along with income. It focuses on making investments in real estate securities, including Reits, secured and unsecured fixed-rate loans and corporate bonds, mezzanine securities, structured products, convertible and preferred securities and equities (public and private), and floating rate securities.

Share on Social Networks: